Lembas, A. et al. 2024. Differences in the course of hepatocellular carcinoma depending on the DAA treatment. Prospects in Pharmaceutical Sciences. 22, 3 (Aug. 2024), 114–119. DOI:https://doi.org/10.56782/pps.236.